Immunoglobulin E-dependent stimulation of human alveolar macrophages: significance in type 1 hypersensitivity. 1986

R W Fuller, and P K Morris, and R Richmond, and D Sykes, and I M Varndell, and D M Kemeny, and P J Cole, and C T Dollery, and J MacDermot

Human alveolar macrophages were obtained during diagnostic bronchoalveolar lavage. Cells were cultured, and morphological examination (including electron microscopy) revealed that not more than 5% of the cultured cells were identifiable as cells other than alveolar macrophages. The cells were sensitized with human myeloma immunoglobulin E. and then challenged with anti-immunoglobulin E anti-sera. The experiments employed a highly specific monoclonal antibody and three affinity purified reagents. The formation of immunoglobulin E/anti-immunoglobulin E complexes facilitated release from alveolar macrophages of leukotriene B4, prostaglandin F2 alpha, thromboxane B2 and the lysosomal hydrolase N-acetyl-beta-D-glucosaminidase. There was no release of active oxygen species, with this stimulus, as measured by lucigenin chemiluminescence. Immunoglobulin E receptors were identified histochemically on the surface of human alveolar macrophages, and were visualized as conjugates with colloidal gold by electron microscopy. These results support the view that human alveolar macrophages may contribute to type 1 hypersensitivity reactions in the lung.

UI MeSH Term Description Entries
D008262 Macrophage Activation The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants. Activation, Macrophage,Activations, Macrophage,Macrophage Activations
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D011650 Pulmonary Alveoli Small polyhedral outpouchings along the walls of the alveolar sacs, alveolar ducts and terminal bronchioles through the walls of which gas exchange between alveolar air and pulmonary capillary blood takes place. Alveoli, Pulmonary,Alveolus, Pulmonary,Pulmonary Alveolus
D011961 Receptors, Fc Molecules found on the surface of some, but not all, B-lymphocytes, T-lymphocytes, and macrophages, which recognize and combine with the Fc (crystallizable) portion of immunoglobulin molecules. Fc Receptors,Fc Receptor,Receptor, Fc
D011971 Receptors, Immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D013929 Thromboxane B2 A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin). B2, Thromboxane
D017455 Receptors, IgE Specific molecular sites on the surface of B- and T-lymphocytes which combine with IgEs. Two subclasses exist: low affinity receptors (Fc epsilon RII) and high affinity receptors (Fc epsilon RI). Antigens, CD23,CD23 Antigens,Fc Receptors, epsilon,Fc epsilon Receptor,Fc epsilon Receptors,IgE Receptor,IgE Receptors,Receptors, Fc epsilon,epsilon Fc Receptor,epsilon Fc Receptors,CD 23 Antigens,CD23 Antigen,Fc epsilon RI,Fc epsilon RII,Immunoglobulin E Receptor,Antigen, CD23,Antigens, CD 23,Fc Receptor, epsilon,Receptor, Fc epsilon,Receptor, IgE,Receptor, Immunoglobulin E,Receptor, epsilon Fc,Receptors, epsilon Fc,epsilon RI, Fc,epsilon RII, Fc,epsilon Receptor, Fc,epsilon Receptors, Fc

Related Publications

R W Fuller, and P K Morris, and R Richmond, and D Sykes, and I M Varndell, and D M Kemeny, and P J Cole, and C T Dollery, and J MacDermot
May 1970, Annals of allergy,
R W Fuller, and P K Morris, and R Richmond, and D Sykes, and I M Varndell, and D M Kemeny, and P J Cole, and C T Dollery, and J MacDermot
February 1993, Veterinary parasitology,
R W Fuller, and P K Morris, and R Richmond, and D Sykes, and I M Varndell, and D M Kemeny, and P J Cole, and C T Dollery, and J MacDermot
May 1980, Clinical and experimental immunology,
R W Fuller, and P K Morris, and R Richmond, and D Sykes, and I M Varndell, and D M Kemeny, and P J Cole, and C T Dollery, and J MacDermot
January 1989, Progress in clinical and biological research,
R W Fuller, and P K Morris, and R Richmond, and D Sykes, and I M Varndell, and D M Kemeny, and P J Cole, and C T Dollery, and J MacDermot
June 2013, Journal of immunological methods,
R W Fuller, and P K Morris, and R Richmond, and D Sykes, and I M Varndell, and D M Kemeny, and P J Cole, and C T Dollery, and J MacDermot
December 1982, Infection and immunity,
R W Fuller, and P K Morris, and R Richmond, and D Sykes, and I M Varndell, and D M Kemeny, and P J Cole, and C T Dollery, and J MacDermot
June 1975, Journal of immunology (Baltimore, Md. : 1950),
R W Fuller, and P K Morris, and R Richmond, and D Sykes, and I M Varndell, and D M Kemeny, and P J Cole, and C T Dollery, and J MacDermot
July 1970, Vox sanguinis,
R W Fuller, and P K Morris, and R Richmond, and D Sykes, and I M Varndell, and D M Kemeny, and P J Cole, and C T Dollery, and J MacDermot
February 1983, The Journal of clinical investigation,
R W Fuller, and P K Morris, and R Richmond, and D Sykes, and I M Varndell, and D M Kemeny, and P J Cole, and C T Dollery, and J MacDermot
July 2010, Nature immunology,
Copied contents to your clipboard!